1. Home
  2. GNLN vs CMND Comparison

GNLN vs CMND Comparison

Compare GNLN & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$0.30

Market Cap

1.6M

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$1.06

Market Cap

1.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
CMND
Founded
2005
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
GNLN
CMND
Price
$0.30
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
284.6K
121.0K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
21.57
N/A
EPS
N/A
N/A
Revenue
$13,275,000.00
N/A
Revenue This Year
$1,541.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.07
52 Week High
$7.73
$3.25

Technical Indicators

Market Signals
Indicator
GNLN
CMND
Relative Strength Index (RSI) 26.61 54.98
Support Level N/A $0.99
Resistance Level $0.89 $1.08
Average True Range (ATR) 0.12 0.10
MACD -0.02 0.07
Stochastic Oscillator 6.58 96.91

Price Performance

Historical Comparison
GNLN
CMND

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: